Wellcome Trust and MRC Cambridge Stem Cell Institute, Wellcome Trust and MRC Cambridge Stem Cell Institute, Wellcome Trust and MRC Cambridge Stem Cell Institute, National University of Singapore (NUS) - Department of Haematology, The Babraham Institute, Wellcome Trust and MRC Cambridge Stem Cell Institute, University of Cambridge - Division of Cellular and Molecular Pathology, St. James’s Institute of Oncology - Haematological Malignancy Diagnostic Service, University of York - Epidemiology and Cancer Statistics Group, National University of Singapore (NUS) - Department of Haematology, Goethe University Frankfurt - Department of Medicine II, Hematology/Oncology, Wellcome Trust and MRC Cambridge Stem Cell Institute, The Francis Crick Institute, Nanyang Technological University (NTU) - School of Biological Sciences, Teesside University - School of Health & Life Sciences, Teesside University - School of Health & Life Sciences, University of Cambridge - Division of Cellular and Molecular Pathology, University of Cambridge - Division of Cellular and Molecular Pathology, National University of Singapore (NUS) - Department of Clinical Translational Research, Addenbrooke’s Hospital - Department of Paediatric Oncology, Nanyang Technological University (NTU) - School of Biological Sciences, Wellcome Trust Sanger Institute, St. James’s Institute of Oncology - Haematological Malignancy Diagnostic Service, Wellcome Genome Campus - Cancer Genome Project, Teesside University - School of Health & Life Sciences, University of Cambridge - Division of Cellular and Molecular Pathology, National Institute of Chemistry Slovenia, University of York - Epidemiology and Cancer Statistics Group, St. James’s Institute of Oncology - Haematological Malignancy Diagnostic Service, Goethe University Frankfurt - Department of Medicine II, Hematology/Oncology, The Babraham Institute - Immunology Programme, University of Cambridge - Division of Cellular and Molecular Pathology, University of Cambridge - MRC Cancer Unit and Wellcome Trust and MRC Cambridge Stem Cell Institute

University of California, Los Angeles (UCLA) - Molecular, Cellular and Integrative Physiology Graduate Program, University of California, Los Angeles (UCLA) - Department of Biological Chemistry, University of California, Los Angeles (UCLA) - Center for Oral and Head/Neck Oncology Research, Northwestern University - Department of Cell and Developmental Biology, Northwestern University - Department of Cell and Developmental Biology, Northwestern University - Robert H. Lurie Comprehensive Cancer Center, The Babraham Institute - Immunology Programme, Northwestern University - Department of Cell and Developmental Biology, University of California, Los Angeles (UCLA) - Department of Biological Chemistry, University of California, Los Angeles (UCLA) - Department of Biological Chemistry and Northwestern University - Department of Cell and Developmental Biology

University of Toulouse 3, Paul Sabatier University - Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), University of Toulouse 3, Paul Sabatier University - Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), University of Toulouse 3, Paul Sabatier University - Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), University of Toulouse 3, Paul Sabatier University - Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), University of Toulouse 3, Paul Sabatier University - Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), The Babraham Institute - Immunology Programme and CHU Purpan - Center for Physiopathology Toulouse-Purpan